Smith Pharma SRL
1.1 FTEThe score of Smith Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +19 % Total assets -13 % Headcount (avg FTE) +83 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Smith Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 56,410 € | ||||
| Equity | 146,292 € | ||||
| Cash | 51,571 € | ||||
| EBITDA | 143,087 € | ||||
| Total assets | 610,521 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Smith Pharma's financial analysis
- Solvency24.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Smith Pharma
Smith Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0507.639.996
- VAT number
- BE0507639996
- Peppol
- Registered · 0208:0507639996 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Dec 2014
- Registered office
- 2830 Willebroek
- Size
- Micro · 1.1 FTE
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Smith Pharma (SRL) has been based in Willebroek since 2014, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 56,410 € and equity of 146,292 €; its revenue is not published. With 1.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 24.0%, below the median of its sector (44.2%).
Companies similar to Smith Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Winterslag Retail sale of pharmaceutical products Genk · balance sheet 604,173 €
- Vermunicht Retail sale of pharmaceutical products Hulshout · balance sheet 602,591 €
- Pharmacie DE LA Jonction Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 601,403 €
- Geassocieerde Apotheek Merksem Retail sale of pharmaceutical products Antwerp · balance sheet 623,918 €
- "Farminco" Retail sale of pharmaceutical products Andenne · balance sheet 589,804 €
- Kapelfarma Retail sale of pharmaceutical products Kontich · balance sheet 653,987 €
- Pharmenform Retail sale of pharmaceutical products Koekelberg · balance sheet 567,837 €
- Farma Booischot Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 558,918 €
Frequently asked questions about Smith Pharma
What is the revenue of Smith Pharma?
Smith Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Smith Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0507639996 for Smith Pharma, if the company is VAT-registered. Its company number (CBE) is 0507.639.996.
Where is the registered office of Smith Pharma?
According to the CBE register, the registered office of Smith Pharma is in 2830 Willebroek.
What is the equity of Smith Pharma?
At the close of the 2025 financial year, the equity of Smith Pharma amounts to 146,292 €, a solvency of 24.0% of total assets.
How many people work at Smith Pharma?
1.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Smith Pharma?
The register lists 2 active mandates at Smith Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Smith Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →